IQX LIMITED More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
George Syrmalis
CEO | Chief Executive Officer | 60 | 14-10-31 |
Kosmas Dimitriou
CHM | Chairman | 44 | 12-10-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 71 | 13-08-13 | |
George Syrmalis
CEO | Chief Executive Officer | 60 | 14-10-31 |
Kosmas Dimitriou
CHM | Chairman | 44 | 12-10-31 |
IQX Limited is an Australia-based investment funds management company specializing in the bioscience sector. The Company operates through two operating segments, financial services and office and shared services. The Company is engaged in investment activities and exploring investment opportunities primarily in Australian biotech and life science companies and other registered intellectual property. It is also engaged in underwriting primary and secondary capital raisings, and managing discretionary accounts. The Company's subsidiaries include iQX Capital Pty Ltd, iQX Investment Services Pty Ltd, Life Science Holdings Pty Ltd, iQ Capital Partners (No.1) Pty Ltd, iQ Series 8 Life Science (Global) LP, Neutron Investment Group Pty Ltd, Life Science Ventures (No.1) Pty Ltd, Prosoma Therapeutics (No.1) Pty Ltd, Prosoma Therapeutics (No.2) Pty Ltd, Prosoma Therapeutics (No.3) Pty Ltd, Prosoma Therapeutics (No.4) Pty Ltd, and Prosoma Therapeutics (No.5) Pty Ltd.
Sector
-
